**6. Conclusion**

Bananas are widely used all over the world as food staples and for medicinal purposes. This is for their interesting bioactive secondary metabolites. Phytochemical and pharmacological studies of bananas and plantain are expanding as it has been demonstrated that *Musa* species extracts possess numerous pharmacological activities, which are ascribed to their phyto-constituents like phenols, carotenoid, and amines. There is a growing interest in developing a banana-based phytomedicine for wound healing and treating Parkinson's disease, considering the ethnopharmacological data available on the potentials of banana fruit. To achieve that, issues such as modality, quality control, efficacy, safety, and toxicity need to be addressed at both preclinical and clinical levels. Finally, looking at the genetic diversity of banana species and its adaptation to different environmental conditions, ethnopharmacological investigations will provide the suitable support needed for clinical usage of secondary metabolites of banana species in modern medicine. Furthermore, thorough phytochemical screening needs to be undertaken to ascertain the active components in different types of extracts of banana parts. This will enrich the literature and provide a solid base for scientific arguments as against the current reliance on empirical and anecdotal assumptions.

## **Acknowledgements**

The authors want to thank Associate Professor Ibrahim Khalil Adam, Dr. Aishatu Muhammad Gadanya, and Dr. Salihu Ibrahim Isma'il for their valuable suggestions and encouragement throughout the preparation of this manuscript.

## **Conflict of interest**

No conflict of interest.
